180+ networks across 21 NJ counties
COMMUNITY ENGAGEMENT CORE OVERVIEW
NJACTS draws leading academic, industry and community groups together to understand and address the health needs of New Jersey. Central to this is engagement with our community to ensure that our efforts respond to their priorities. Our goal is to conduct research with the New Jersey community, in the community and for the community, and yet, have impact beyond our state’s boundaries.
Stay in Touch!
Join RCommunity!
Join Rutgers Health Service Corps!
Empowering Community-Based Research
Through Cultural and Linguistic Collaboration
- Navigating interpreter-mediated encounters
- Effective translation for research
- Understanding cultural nuances in literacy, trust, and belonging
Through collaboration across disciplines and leveraging expertise within and beyond Rutgers, CrEER ensures that research is culturally relevant and impactful both locally and globally.
👉 Discover how CrEER is shaping the future of community-based research here.
Association for Clinical and Translational Science (ATCS) Membership for Community Members
Did you know that community members are eligible to become members of ACTS through their affiliation with NJ ACTS?
Community members are able to access ACTS’ member benefits, including:
- Discounted registration to the annual Translational Science meeting
- Opportunities to participate in Special Interest Groups and Committees
- Access to the community platform website and more!
Resource for Investigators – CTSA Compendium of D&I Catalogs
Dissemination and implementation (D&I) research focuses on translating evidence-based interventions into real-world settings to improve health outcomes in the broader community.
An open-source CTSA Compendium of D&I Catalogs has been developed by the Clinical & Translational Science Awards (CTSA) Program’s “Advancing Dissemination and Implementation Sciences in CTSAs” working group to support investigators at any stage of their D&I skill-building journey. It provides a curated list of resource catalogs relevant to the conduct of D&I science. The materials include frameworks/theories/models, methods/measures, funding resources, and practice and training resources.
Click here to learn more.
CIRTification – A New Alternative to CITI for Community Partners
The rollout of CIRTification at Rutgers has begun. The CIRTification program provides research ethics training alternatives for individuals in community organizations, with limited understanding of conducting human research and protecting potential research participants. This option provides training focused on equipping community partners to conduct human subject research effectively and safely in their communities.
To learn more about the program at Rutgers, please visit this link CIRTification.
NJ ACTS COMMUNITY SCIENTIST PROGRAM
This program is designed to provide researchers with rapid feedback from expert community members to ensure their research projects are culturally appropriate and relevant to the community.
PARTICIPATE IN OUR NEXT COHORT!
For more information, please contact njactscommunity@rwjms.rutgers.edu
NJ HEROES TOO
Through the ongoing New Jersey Healthcare Essential Worker Outreach and Education Study – Testing Overlooked Occupations (NJ HEROES TOO), we have gained a wealth of data on COVID-19’s effects, gleaned valuable learnings on attitudes toward testing and vaccines, and improved COVID-19 awareness in underserved communities.
Community Blog
NIH Loan Repayment Programs (LRPs)
The NIH Loan Repayment Programs (LRPs) are a set of programs established by Congress and designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers. NCATS participates in the Clinical Research, Pediatric...
2020 NIH Rural Health Seminar: Challenges in the Era of COVID-19
Join the National Institute on Minority Health and Health Disparities (NIMHD) and the National Center for Advancing Translational Sciences (NCATS) for the 2020 NIH Rural Health Seminar: Challenges in the Era of COVID-19. The seminar will bring together researchers,...
As Pfizer prepares to seek authorization for vaccine, FDA vows transparency
With coronavirus cases surging in the United States, the need for a vaccine is growing increasingly urgent, but federal officials have sought in recent days to reassure the public that the approval process for any potential vaccine will be thorough and...
Assessing COVID-19’s toll on Black physicians’ practices
As Dr. Pamela Huffman-DeVaughn watched some of her colleagues close the doors of their private practices, she feared she might have to do the same. Like many small-business owners, the physician felt the effects of the coronavirus. During the height of the pandemic,...
New Jersey Innovation Institute’s BioCentriq Aims to Usher in a New Era in Cell and Gene Therapies
To overcome production hurdles for cell and gene therapies, a promising new class of biologic medications, NJIT’s New Jersey Innovation Institute (NJII) has opened clinical-scale centers that will work directly with drug developers to streamline the processing of new...
Listen to Dr. Panettieri interview on the Pfizer vaccine
Listen to Dr. Panettieri, the Vice Chancellor for Translational Medicine and Science at Rutgers University interview on 1010 WINS. As he reacts to Pfizer's vaccine 95% effectiveness in preventing infections.